Clinical blockade of PD1 and LAG3-potential mechanisms of action

被引：514

作者：

Nguyen, Linh T. ^{[1
]}

Ohashi, Pamela S. ^{[1
]}

机构：

[1] Princess Margaret Canc Ctr, Immune Therapy Program, Toronto, ON M5G 2M9, Canada

来源：

NATURE REVIEWS IMMUNOLOGY | 2015年 / 15卷 / 01期

关键词：

T-CELL-ACTIVATION; CHRONIC VIRAL-INFECTION; LYMPHOCYTE-ACTIVATION; PROGRAMMED DEATH-1; PHASE-I; ADVANCED MELANOMA; IMMUNE-RESPONSES; PD-1; EXPRESSION; B-CELLS; INHIBITORY RECEPTORS;

D O I：

10.1038/nri3790

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Dysfunctional T cells can render the immune system unable to eliminate infections and cancer. Therapeutic targeting of the surface receptors that inhibit T cell function has begun to show remarkable success in clinical trials. In this Review, we discuss the potential mechanisms of action of the clinical agents that target two of these receptors, programmed cell death protein 1 (PD1) and lymphocyte activation gene 3 protein (LAG3). We also suggest correlative studies that may define the predominant mechanisms of action and identify predictive biomarkers.

引用

页码：45 / 56

页数：12

共 125 条

[111] PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells [J].

Wang, Wenshi ;

Lau, Roy ;

Yu, Daohai ;

Zhu, Weiwei ;

Korman, Alan ;

Weber, Jeffrey .

INTERNATIONAL IMMUNOLOGY, 2009, 21 (09) :1065-1077

[112] LYMPHOPROLIFERATIVE DISORDERS WITH EARLY LETHALITY IN MICE DEFICIENT IN CTLA-4 [J].

WATERHOUSE, P ;

PENNINGER, JM ;

TIMMS, E ;

WAKEHAM, A ;

SHAHINIAN, A ;

LEE, KP ;

THOMPSON, CB ;

GRIESSER, H ;

MAK, TW .

SCIENCE, 1995, 270 (5238) :985-988

[113] Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma [J].

Weber, Jeffrey S. ;

Kudchadkar, Ragini Reiney ;

Yu, Bin ;

Gallenstein, Donna ;

Horak, Christine E. ;

Inzunza, H. David ;

Zhao, Xiuhua ;

Martinez, Alberto J. ;

Wang, Wenshi ;

Gibney, Geoffrey ;

Kroeger, Jodi ;

Eysmans, Cabell ;

Sarnaik, Amod A. ;

Chen, Y. Ann .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) :4311-U50

[114] Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial [J].

Westin, Jason R. ;

Chu, Fuliang ;

Zhang, Min ;

Fayad, Luis E. ;

Kwak, Larry W. ;

Fowler, Nathan ;

Romaguera, Jorge ;

Hagemeister, Fredrick ;

Fanale, Michelle ;

Samaniego, Felipe ;

Feng, Lei ;

Baladandayuthapani, Veerabhadran ;

Wang, Zhiqiang ;

Ma, Wencai ;

Gao, Yanli ;

Wallace, Michael ;

Vence, Luis M. ;

Radvanyi, Laszlo ;

Muzzafar, Tariq ;

Rotem-Yehudar, Rinat ;

Davis, R. Eric ;

Neelapu, Sattva S. .

LANCET ONCOLOGY, 2014, 15 (01) :69-77

[115] Molecular signature of CD8+ T cell exhaustion during chronic viral infection [J].

Wherry, E. John ;

Ha, Sang-Jun ;

Kaech, Susan M. ;

Haining, W. Nicholas ;

Sarkar, Surojit ;

Kalia, Vandana ;

Subramaniam, Shruti ;

Blattman, Joseph N. ;

Barber, Daniel L. ;

Ahmed, Rafi .

IMMUNITY, 2007, 27 (04) :670-684

[116] T cell exhaustion [J].

Wherry, E. John .

NATURE IMMUNOLOGY, 2011, 12 (06) :492-499

[117] Nivolumab plus Ipilimumab in Advanced Melanoma [J].

Wolchok, Jedd D. ;

Kluger, Harriet ;

Callahan, Margaret K. ;

Postow, Michael A. ;

Rizvi, Naiyer A. ;

Lesokhin, Alexander M. ;

Segal, Neil H. ;

Ariyan, Charlotte E. ;

Gordon, Ruth-Ann ;

Reed, Kathleen ;

Burke, Matthew M. ;

Caldwell, Anne ;

Kronenberg, Stephanie A. ;

Agunwamba, Blessing U. ;

Zhang, Xiaoling ;

Lowy, Israel ;

Inzunza, Hector David ;

Feely, William ;

Horak, Christine E. ;

Hong, Quan ;

Korman, Alan J. ;

Wigginton, Jon M. ;

Gupta, Ashok ;

Sznol, Mario .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :122-133

[118] Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape [J].

Woo, Seng-Ryong ;

Turnis, Meghan E. ;

Goldberg, Monica V. ;

Bankoti, Jaishree ;

Selby, Mark ;

Nirschl, Christopher J. ;

Bettini, Matthew L. ;

Gravano, David M. ;

Vogel, Peter ;

Liu, Chih Long ;

Tangsombatvisit, Stephanie ;

Grosso, Joseph F. ;

Netto, George ;

Smeltzer, Matthew P. ;

Chaux, Alcides ;

Utz, Paul J. ;

Workman, Creg J. ;

Pardoll, Drew M. ;

Korman, Alan J. ;

Drake, Charles G. ;

Vignali, Dario A. A. .

CANCER RESEARCH, 2012, 72 (04) :917-927

[119] Negative regulation of T cell homeostasisby lymphocyte activation gene-3 (CD223) [J].

Workman, CJ ;

Vignali, DAA .

JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :688-695

[120] Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo [J].

Workman, CJ ;

Cauley, LS ;

Kim, IJ ;

Blackman, MA ;

Woodland, DL ;

Vignali, DAA .

JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5450-5455

← 4 5 6 7 8 9 10 11 12 13 →